Influence of Excipients on Cocrystal Stability and Formation

被引:21
作者
Aljohani, Marwah [1 ]
McArdle, Patrick [1 ,2 ]
Erxleben, Andrea [1 ,2 ]
机构
[1] Natl Univ Ireland, Sch Chem, Galway H91 TK33, Ireland
[2] Synth & Solid State Pharmaceut Ctr SSPC, Limerick V94 T9PX, Ireland
基金
爱尔兰科学基金会;
关键词
PHARMACEUTICAL COCRYSTALS; PHYSICAL STABILITY; DISSOCIATION; COFORMER; SOLUBILITY; THEOPHYLLINE;
D O I
10.1021/acs.cgd.0c00321
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cocrystal formation is widely used to modify and optimize the physicochemical properties of an active pharmaceutical ingredient (API). However, the stability of cocrystals toward formulation with excipients is little investigated. In this work, the effect of grinding in the presence of the common excipients polyvinylpyrrolidone (PVP) and microcrystalline cellulose (MCC) on 11 cocrystals and a salt of the sulfonamide diuretic chlorothiazide (ctz) was studied (ctz-bipy, ctz-ebipy, ctz-pbipy, ctz-pyr, ctzhyp, ctz-hma, ctz-bza, ctz-nia, ctz-ina, ctz-cbz, ctz-aca, ctz-ppa, (bzamH(+))(ctz(-)); bipy = 4,4'-bipyridine, ebipy = 1,2-di(4-pyridyl)ethylene, pbipy = 1,3-di(4-pyridyl)propane, pyr = pyrazine, hyp = 2-hydroxypyridine, hma = hexamethylenetetramine, bza = benzamide, nia = nicotinamide, ina = isonicotinamide, cbz = carbamazepine, aca = acetamide, ppa = propionamide, bzamH+ = benzamidinium). Except for ctz-ppa and ctz-aca, all cocrystals were stable toward milling with 1 weight equiv PVP or MCC. It was also shown that the cocrystals ctz-bipy, ctz-ebipy, ctz-pbipy, ctz-pyr, ctz-hma, ctz-bza, ctz-ina, ctz-cbz, and the salt (bzamH+)(ctz-) formed in situ, when ctz was milled with the respective coformer in the presence of PVP or MCC. The stability and formation of ctz-cbz, ctz-nia, and htz-nia (htz = hydrochlorothiazide) toward grinding with a wider range of excipients (HPC, alpha-lactose, deoxycholic acid, and sodium taurocholate) was also investigated, and the results are discussed with regard to the heterosynthons of the ctz cocrystals and competing H bonding with the excipients.
引用
收藏
页码:4523 / 4532
页数:10
相关论文
共 45 条
[1]   A Comprehensive Cocrystal Screening Study of Chlorothiazide [J].
Aljohani, Marwah ;
Pallipurath, Anuradha R. ;
McArdle, Patrick ;
Erxleben, Andrea .
CRYSTAL GROWTH & DESIGN, 2017, 17 (10) :5223-5232
[2]   Coformer Replacement as an Indicator for Thermodynamic Instability of Cocrystals: Competitive Transformation of Caffeine:Dicarboxylic Acid [J].
Alsirawan, Mhd. Bashir ;
Vangala, Venu R. ;
Kendrick, John ;
Leusen, Frank J. J. ;
Paradkar, Anant .
CRYSTAL GROWTH & DESIGN, 2016, 16 (06) :3072-3075
[3]   Cocrystal Forms of the BCS Class IV Drug Sulfamethoxazole [J].
Alsubaie, Moneerh ;
Aljohani, Marwah ;
Erxleben, Andrea ;
McArdle, Patrick .
CRYSTAL GROWTH & DESIGN, 2018, 18 (07) :3902-3912
[4]   Brexpiprazole-catechol cocrystal: structure elucidation, excipient compatibility and stability [J].
Arabiani, Mohsin R. ;
Raju, Bal K. ;
Bhunia, Surojit ;
Teja, Pyla Kranthi ;
Lodagekar, Anurag ;
Chavan, Rahul B. ;
Shastri, Nalini R. ;
Reddy, C. Malla ;
Shelat, Pragna ;
Dave, Divyang .
CRYSTENGCOMM, 2019, 21 (44) :6703-6708
[5]   Mechanochemical synthesis of pyrazine: dicarboxylic acid cocrystals and a study of dissociation by quantitative phase analysis [J].
Arhangelskis, Mihails ;
Lloyd, Gareth O. ;
Jones, William .
CRYSTENGCOMM, 2012, 14 (16) :5203-5208
[6]   Mitigating Cocrystal Physical Stability Liabilities in Preclinical Formulations [J].
Bhardwaj, Sunny ;
Lipert, Maya ;
Bak, Annette .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (01) :31-38
[7]   Pharmaceutical co-crystals - are we there yet? [J].
Blagden, N. ;
Colesb, S. J. ;
Berry, D. J. .
CRYSTENGCOMM, 2014, 16 (26) :5753-5761
[8]   Excipients for direct compaction - an update [J].
Bolhuis, GK ;
Armstrong, NA .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2006, 11 (01) :111-124
[9]   Pharmaceutical cocrystals: walking the talk [J].
Bolla, Geetha ;
Nangia, Ashwini .
CHEMICAL COMMUNICATIONS, 2016, 52 (54) :8342-8360
[10]  
Buhler V., 2005, Polyvinylpyrrolidone Excipients for Pharmaceuticals: Povidone, Crospovidone and Copovidone, P1, DOI [10.1007/b138598, DOI 10.1007/B138598]